Which has stronger valuation and earnings, RBRK or DLB?

Dolby Laboratories has higher revenue and earnings than Rubrik. Rubrik is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Rubrik $1.32B 13.86 -$348.83M -$1.26 N/A Dolby Laboratories $1.35B 4.25 $255.02M $2.35 26.06

Does the media prefer RBRK or DLB?

In the previous week, Rubrik had 27 more articles in the media than Dolby Laboratories. MarketBeat recorded 52 mentions for Rubrik and 25 mentions for Dolby Laboratories. Rubrik's average media sentiment score of 0.57 beat Dolby Laboratories' score of 0.29 indicating that Rubrik is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rubrik 11 Very Positive mention(s) 9 Positive mention(s) 19 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Dolby Laboratories 5 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor NTNX or DLB?

In the previous week, Nutanix had 38 more articles in the media than Dolby Laboratories. MarketBeat recorded 63 mentions for Nutanix and 25 mentions for Dolby Laboratories. Nutanix's average media sentiment score of 0.72 beat Dolby Laboratories' score of 0.29 indicating that Nutanix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nutanix 18 Very Positive mention(s) 6 Positive mention(s) 17 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Dolby Laboratories 5 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor DLB or GEN?

In the previous week, Dolby Laboratories and Dolby Laboratories both had 25 articles in the media. Gen Digital's average media sentiment score of 1.29 beat Dolby Laboratories' score of 0.29 indicating that Gen Digital is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dolby Laboratories 5 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Gen Digital 21 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend DLB or NLOK?

Dolby Laboratories currently has a consensus price target of $83.00, suggesting a potential upside of 35.55%. Given Dolby Laboratories' stronger consensus rating and higher possible upside, analysts clearly believe Dolby Laboratories is more favorable than NortonLifeLock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dolby Laboratories 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 NortonLifeLock 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Dolby Laboratories (DLB) Competitors

$61.34 -0.09 (-0.15%)

As of 10:26 AM Eastern

Compare

DLB vs. RBRK, NTNX, GEN, NLOK, and CHKP

Should you buy Dolby Laboratories stock or one of its competitors? Dolby Laboratories's main competitors and comparable companies include Rubrik (RBRK), Nutanix (NTNX), Gen Digital (GEN), NortonLifeLock (NLOK), and Check Point Software Technologies (CHKP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "systems software" industry.

How does Dolby Laboratories compare to Rubrik?

Rubrik (NYSE:RBRK) and Dolby Laboratories (NYSE:DLB) are both technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

Rubrik has a beta of 1.24, indicating that its stock price is 24% more volatile than the broader market. Comparatively, Dolby Laboratories has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

Dolby Laboratories has a net margin of 16.70% compared to Rubrik's net margin of -16.50%. Dolby Laboratories' return on equity of 11.08% beat Rubrik's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rubrik	-16.50%	N/A	-8.57%
Dolby Laboratories	16.70%	11.08%	9.04%

Dolby Laboratories has higher revenue and earnings than Rubrik. Rubrik is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rubrik	$1.32B	13.86	-$348.83M	-$1.26	N/A
Dolby Laboratories	$1.35B	4.25	$255.02M	$2.35	26.06

In the previous week, Rubrik had 27 more articles in the media than Dolby Laboratories. MarketBeat recorded 52 mentions for Rubrik and 25 mentions for Dolby Laboratories. Rubrik's average media sentiment score of 0.57 beat Dolby Laboratories' score of 0.29 indicating that Rubrik is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rubrik	11 Very Positive mention(s)	9 Positive mention(s)	19 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
Dolby Laboratories	5 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Rubrik presently has a consensus target price of $112.15, suggesting a potential upside of 26.56%. Dolby Laboratories has a consensus target price of $83.00, suggesting a potential upside of 35.55%. Given Dolby Laboratories' higher possible upside, analysts plainly believe Dolby Laboratories is more favorable than Rubrik.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rubrik	1 Sell rating(s)	0 Hold rating(s)	29 Buy rating(s)	0 Strong Buy rating(s)	2.93
Dolby Laboratories	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

49.5% of Rubrik shares are owned by institutional investors. Comparatively, 58.6% of Dolby Laboratories shares are owned by institutional investors. 13.7% of Rubrik shares are owned by insiders. Comparatively, 37.9% of Dolby Laboratories shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Dolby Laboratories beats Rubrik on 10 of the 16 factors compared between the two stocks.

How does Dolby Laboratories compare to Nutanix?

Nutanix (NASDAQ:NTNX) and Dolby Laboratories (NYSE:DLB) are both technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

In the previous week, Nutanix had 38 more articles in the media than Dolby Laboratories. MarketBeat recorded 63 mentions for Nutanix and 25 mentions for Dolby Laboratories. Nutanix's average media sentiment score of 0.72 beat Dolby Laboratories' score of 0.29 indicating that Nutanix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nutanix	18 Very Positive mention(s)	6 Positive mention(s)	17 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Positive
Dolby Laboratories	5 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Nutanix has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market. Comparatively, Dolby Laboratories has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

Nutanix currently has a consensus target price of $72.71, indicating a potential upside of 9.39%. Dolby Laboratories has a consensus target price of $83.00, indicating a potential upside of 35.55%. Given Dolby Laboratories' higher probable upside, analysts clearly believe Dolby Laboratories is more favorable than Nutanix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutanix	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.50
Dolby Laboratories	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Nutanix has a net margin of 52.81% compared to Dolby Laboratories' net margin of 16.70%. Dolby Laboratories' return on equity of 11.08% beat Nutanix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutanix	52.81%	-90.13%	9.09%
Dolby Laboratories	16.70%	11.08%	9.04%

Nutanix has higher revenue and earnings than Dolby Laboratories. Nutanix is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutanix	$2.85B	6.30	$1.51B	$5.16	12.88
Dolby Laboratories	$1.35B	4.25	$255.02M	$2.35	26.06

85.3% of Nutanix shares are owned by institutional investors. Comparatively, 58.6% of Dolby Laboratories shares are owned by institutional investors. 2.4% of Nutanix shares are owned by insiders. Comparatively, 37.9% of Dolby Laboratories shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Nutanix beats Dolby Laboratories on 11 of the 16 factors compared between the two stocks.

How does Dolby Laboratories compare to Gen Digital?

Dolby Laboratories (NYSE:DLB) and Gen Digital (NASDAQ:GEN) are both technology companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings, valuation and media sentiment.

Dolby Laboratories currently has a consensus target price of $83.00, indicating a potential upside of 35.55%. Gen Digital has a consensus target price of $31.60, indicating a potential upside of 5.19%. Given Dolby Laboratories' higher probable upside, research analysts clearly believe Dolby Laboratories is more favorable than Gen Digital.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dolby Laboratories	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Gen Digital	0 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.38

Dolby Laboratories pays an annual dividend of $1.44 per share and has a dividend yield of 2.4%. Gen Digital pays an annual dividend of $0.50 per share and has a dividend yield of 1.7%. Dolby Laboratories pays out 61.3% of its earnings in the form of a dividend. Gen Digital pays out 29.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Dolby Laboratories has raised its dividend for 10 consecutive years. Dolby Laboratories is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Dolby Laboratories has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market. Comparatively, Gen Digital has a beta of 1.22, meaning that its stock price is 22% more volatile than the broader market.

58.6% of Dolby Laboratories shares are owned by institutional investors. Comparatively, 81.4% of Gen Digital shares are owned by institutional investors. 37.9% of Dolby Laboratories shares are owned by insiders. Comparatively, 9.7% of Gen Digital shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Gen Digital has a net margin of 20.73% compared to Dolby Laboratories' net margin of 16.70%. Gen Digital's return on equity of 55.93% beat Dolby Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dolby Laboratories	16.70%	11.08%	9.04%
Gen Digital	20.73%	55.93%	8.91%

In the previous week, Dolby Laboratories and Dolby Laboratories both had 25 articles in the media. Gen Digital's average media sentiment score of 1.29 beat Dolby Laboratories' score of 0.29 indicating that Gen Digital is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dolby Laboratories	5 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Gen Digital	21 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Gen Digital has higher revenue and earnings than Dolby Laboratories. Gen Digital is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dolby Laboratories	$1.35B	4.25	$255.02M	$2.35	26.06
Gen Digital	$5B	3.60	$973M	$1.72	17.47

Summary

Gen Digital beats Dolby Laboratories on 10 of the 19 factors compared between the two stocks.

How does Dolby Laboratories compare to NortonLifeLock?

Dolby Laboratories (NYSE:DLB) and NortonLifeLock (NASDAQ:NLOK) are both technology companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.

In the previous week, Dolby Laboratories had 25 more articles in the media than NortonLifeLock. MarketBeat recorded 25 mentions for Dolby Laboratories and 0 mentions for NortonLifeLock. Dolby Laboratories' average media sentiment score of 0.29 beat NortonLifeLock's score of 0.00 indicating that Dolby Laboratories is being referred to more favorably in the media.

Company	Overall Sentiment
Dolby Laboratories	Neutral
NortonLifeLock	Neutral

58.6% of Dolby Laboratories shares are held by institutional investors. Comparatively, 94.9% of NortonLifeLock shares are held by institutional investors. 37.9% of Dolby Laboratories shares are held by company insiders. Comparatively, 3.3% of NortonLifeLock shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Dolby Laboratories pays an annual dividend of $1.44 per share and has a dividend yield of 2.4%. NortonLifeLock pays an annual dividend of $0.50 per share and has a dividend yield of 1.6%. Dolby Laboratories pays out 61.3% of its earnings in the form of a dividend. NortonLifeLock pays out 35.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Dolby Laboratories has raised its dividend for 10 consecutive years. Dolby Laboratories is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Dolby Laboratories has a net margin of 16.70% compared to NortonLifeLock's net margin of 0.00%. Dolby Laboratories' return on equity of 11.08% beat NortonLifeLock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dolby Laboratories	16.70%	11.08%	9.04%
NortonLifeLock	N/A	N/A	N/A

NortonLifeLock has higher revenue and earnings than Dolby Laboratories. NortonLifeLock is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dolby Laboratories	$1.35B	4.25	$255.02M	$2.35	26.06
NortonLifeLock	$2.82B	6.29	$817.05M	$1.43	21.68

Dolby Laboratories currently has a consensus price target of $83.00, suggesting a potential upside of 35.55%. Given Dolby Laboratories' stronger consensus rating and higher possible upside, analysts clearly believe Dolby Laboratories is more favorable than NortonLifeLock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dolby Laboratories	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
NortonLifeLock	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Dolby Laboratories has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market. Comparatively, NortonLifeLock has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market.

Summary

Dolby Laboratories beats NortonLifeLock on 14 of the 19 factors compared between the two stocks.

How does Dolby Laboratories compare to Check Point Software Technologies?

Dolby Laboratories (NYSE:DLB) and Check Point Software Technologies (NASDAQ:CHKP) are both technology companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations, valuation and media sentiment.

Check Point Software Technologies has higher revenue and earnings than Dolby Laboratories. Check Point Software Technologies is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dolby Laboratories	$1.35B	4.25	$255.02M	$2.35	26.06
Check Point Software Technologies	$2.73B	5.11	$1.06B	$9.77	13.97

58.6% of Dolby Laboratories shares are owned by institutional investors. Comparatively, 98.5% of Check Point Software Technologies shares are owned by institutional investors. 37.9% of Dolby Laboratories shares are owned by company insiders. Comparatively, 29.0% of Check Point Software Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Check Point Software Technologies has a net margin of 37.93% compared to Dolby Laboratories' net margin of 16.70%. Check Point Software Technologies' return on equity of 38.80% beat Dolby Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dolby Laboratories	16.70%	11.08%	9.04%
Check Point Software Technologies	37.93%	38.80%	15.60%

Dolby Laboratories has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market. Comparatively, Check Point Software Technologies has a beta of 0.5, indicating that its stock price is 50% less volatile than the broader market.

Dolby Laboratories presently has a consensus target price of $83.00, indicating a potential upside of 35.55%. Check Point Software Technologies has a consensus target price of $149.67, indicating a potential upside of 9.65%. Given Dolby Laboratories' higher probable upside, equities analysts plainly believe Dolby Laboratories is more favorable than Check Point Software Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dolby Laboratories	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Check Point Software Technologies	0 Sell rating(s)	18 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Dolby Laboratories had 19 more articles in the media than Check Point Software Technologies. MarketBeat recorded 25 mentions for Dolby Laboratories and 6 mentions for Check Point Software Technologies. Check Point Software Technologies' average media sentiment score of 1.09 beat Dolby Laboratories' score of 0.29 indicating that Check Point Software Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dolby Laboratories	5 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Check Point Software Technologies	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Check Point Software Technologies beats Dolby Laboratories on 11 of the 16 factors compared between the two stocks.

Get Dolby Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DLB vs. The Competition

Export

Metric	Dolby Laboratories	Software Industry	Technology Sector	NYSE Exchange
Market Cap	$5.73B	$16.26B	$29.70B	$24.02B
Dividend Yield	2.34%	3.39%	2.73%	3.72%
P/E Ratio	26.04	138.73	75.22	29.58
Price / Sales	4.25	1,289.35	585.09	19.34
Price / Cash	14.42	49.63	49.52	32.44
Price / Book	2.21	7.36	9.17	7.55
Net Income	$255.02M	$436.23M	$677.06M	$1.07B
7 Day Performance	-5.83%	-1.11%	-2.15%	-1.83%
1 Month Performance	4.17%	3.76%	1.81%	0.58%
1 Year Performance	-15.11%	3.61%	184.04%	12.39%

Dolby Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DLB Dolby Laboratories	4.4846 of 5 stars	$61.34 -0.1%	$83.00 +35.3%	-14.3%	$5.75B	$1.35B	26.10	2,051
RBRK Rubrik	3.3274 of 5 stars	$98.03 -2.1%	$102.00 +4.0%	-1.3%	$20.60B	$1.32B	N/A	3,797	Earnings Report Analyst Forecast
NTNX Nutanix	4.0448 of 5 stars	$66.68 -1.4%	$61.86 -7.2%	-0.8%	$18.28B	$2.54B	70.19	7,800	Trending News Earnings Report Analyst Downgrade Analyst Revision
GEN Gen Digital	4.3573 of 5 stars	$29.11 +0.6%	$31.67 +8.8%	-0.6%	$17.32B	$5.08B	16.92	3,900	Positive News
NLOK NortonLifeLock	N/A	$28.93 +2.7%	N/A	+2.6%	$16.53B	$2.82B	20.23	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:DLB) was last updated on 9/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dolby Laboratories (DLB) Competitors

DLB vs. RBRK, NTNX, GEN, NLOK, and CHKP

How does Dolby Laboratories compare to Rubrik?

Summary

How does Dolby Laboratories compare to Nutanix?

Summary

How does Dolby Laboratories compare to Gen Digital?

Summary

How does Dolby Laboratories compare to NortonLifeLock?

Summary

How does Dolby Laboratories compare to Check Point Software Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DLB vs. The Competition

Dolby Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Dolby Laboratories (DLB) Competitors

DLB vs. RBRK, NTNX, GEN, NLOK, and CHKP

How does Dolby Laboratories compare to Rubrik?

Which has more volatility and risk, RBRK or DLB?

Is RBRK or DLB more profitable?

Which has stronger valuation and earnings, RBRK or DLB?

Does the media prefer RBRK or DLB?

Do analysts prefer RBRK or DLB?

Do insiders & institutionals hold more shares of RBRK or DLB?

Summary

How does Dolby Laboratories compare to Nutanix?

Does the media favor NTNX or DLB?

Which has more volatility and risk, NTNX or DLB?

Do analysts rate NTNX or DLB?

Is NTNX or DLB more profitable?

Which has better earnings and valuation, NTNX or DLB?

Do institutionals and insiders believe in NTNX or DLB?

Summary

How does Dolby Laboratories compare to Gen Digital?

Do analysts rate DLB or GEN?

Is DLB or GEN a better dividend stock?

Which has more volatility & risk, DLB or GEN?

Do insiders and institutionals believe in DLB or GEN?

Is DLB or GEN more profitable?

Does the media favor DLB or GEN?

Which has preferable earnings and valuation, DLB or GEN?

Summary

How does Dolby Laboratories compare to NortonLifeLock?

Does the media favor DLB or NLOK?

Do institutionals and insiders hold more shares of DLB or NLOK?

Is DLB or NLOK a better dividend stock?

Is DLB or NLOK more profitable?

Which has stronger valuation & earnings, DLB or NLOK?

Do analysts recommend DLB or NLOK?

Which has more volatility & risk, DLB or NLOK?

Summary

How does Dolby Laboratories compare to Check Point Software Technologies?

Which has stronger earnings and valuation, DLB or CHKP?

Do insiders and institutionals believe in DLB or CHKP?

Is DLB or CHKP more profitable?

Which has more risk & volatility, DLB or CHKP?

Do analysts recommend DLB or CHKP?

Does the media favor DLB or CHKP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DLB vs. The Competition

Dolby Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools